Aggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa - Scorecard - MDSpire

Aggressive Juvenile-Onset Respiratory Papillomatosis in a High HIV Prevalence Setting: Clinical Predictors of Severity in South Africa

  • By

  • L A Sibiya

  • T Abel

  • S Maistry

  • R Seedat

  • J Z Porterfield

  • Y Liang

  • E Evangelista

  • M Tyle

  • Y Saman

  • N Msomi

  • December 15, 2025

  • 0 min

Share

Clinical Scorecard: Severe Juvenile-Onset Respiratory Papillomatosis in Regions with High HIV Rates: Identifying Clinical Indicators of Severity in South Africa

At a Glance

CategoryDetail
ConditionJuvenile-onset recurrent respiratory papillomatosis (JoRRP), a chronic HPV-driven disease causing recurrent airway papillomas
Key MechanismsHPV types 6 and 11 infection acquired primarily via vertical transmission during vaginal delivery; immunosuppression from HIV may increase severity
Target PopulationChildren diagnosed with JoRRP, predominantly ≤12 years old, in high HIV-prevalence regions such as KwaZulu-Natal, South Africa
Care SettingProvincial quaternary referral hospital and resource-limited healthcare settings managing pediatric airway papillomatosis

Key Highlights

  • Incidence of JoRRP in KwaZulu-Natal is 3.82 per 100,000 live births, higher than global averages
  • Early age at diagnosis (≤2 years) and exposure to maternal HIV are significant predictors of aggressive JoRRP
  • Aggressive disease is characterized by frequent surgical interventions and potential pulmonary involvement, increasing morbidity

Guideline-Based Recommendations

Diagnosis

  • Histological confirmation of papillomas in children ≤12 years presenting with airway symptoms
  • Consider early diagnosis in children presenting with progressive hoarseness, stridor, or respiratory distress
  • Assess maternal HIV exposure history as part of clinical evaluation

Management

  • Surgical intervention to maintain airway patency, with attention to frequency of procedures to identify aggressive disease
  • Integrated maternal–child healthcare approaches to reduce vertical HPV and HIV transmission
  • Implementation and expansion of HPV vaccination programs targeting prevention

Monitoring & Follow-up

  • Close follow-up for children diagnosed ≤2 years due to higher risk of aggressive disease
  • Monitor for extralaryngeal and pulmonary involvement, especially in children exposed to maternal HIV
  • Track frequency of surgical interventions to identify disease progression

Risks

  • Risk of airway obstruction and respiratory distress from papilloma proliferation
  • Potential for malignant transformation in approximately 1% of cases
  • Increased severity and pulmonary spread associated with early diagnosis age and maternal HIV exposure

Patient & Prescribing Data

Children with JoRRP aged ≤12 years in high HIV-prevalence settings

Frequent surgical interventions are common in aggressive disease; early identification of risk factors can guide resource allocation and preventive strategies

Clinical Best Practices

  • Early recognition of progressive hoarseness and airway symptoms in young children for prompt diagnosis
  • Incorporate maternal HIV status and exposure history into clinical risk assessment
  • Prioritize HPV vaccination and HIV prevention strategies in maternal and child health programs
  • Use frequency of surgical interventions as a marker for disease aggressiveness to tailor management
  • Ensure multidisciplinary care involving infectious disease, otolaryngology, and public health services

References

Original Source(s)

Related Content